Search

Your search keyword '"Onofri, Agnese"' showing total 21 results
Start Over Author "Onofri, Agnese"
21 results on '"Onofri, Agnese"'

2. Gender-related stress factors and emotional perception in migraine: a structured online questionnaire in migraine patients and controls

Author

Delussi, Marianna, Piraino, Giulia, Guerzoni, Simona, Castro, Flavia Lo, Sances, Grazia, Guaschino, Elena, Vaghi, Gloria, Grazzi, Licia, Sacco, Simona, Onofri, Agnese, Paparella, Giulia, Prudenzano, Maria Pia, Roca, Maria Elena, Fallacara, Adriana, Cevoli, Sabina, Pierangeli, Giulia, Sarchielli, Paola, Bellotti, Alessia, Invitto, Sara, and de Tommaso, Marina

Published
2024
Full Text
View/download PDF

3. Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort Study

Author

Caponnetto, Valeria, Russo, Antonio, Silvestro, Marcello, Tessitore, Alessandro, De Icco, Roberto, Vaghi, Gloria, Sances, Grazia, Tassorelli, Cristina, Baraldi, Carlo, Castro, Flavia Lo, Guerzoni, Simona, Prudenzano, Maria Pia, Fallacara, Adriana, Gentile, Martino, Ornello, Raffaele, Onofri, Agnese, Burgalassi, Andrea, Chiarugi, Alberto, De Cesaris, Francesco, Granato, Antonio, Casalena, Alfonsina, De Tommaso, Marina, Mampreso, Edoardo, Merlo, Paola, Coppola, Gianluca, Battistini, Stefania, Rebecchi, Valentina, Rainero, Innocenzo, Sepe, Federica Nicoletta, Dalla Volta, Giorgio, Sacco, Simona, Geppetti, Pierangelo, and Iannone, Luigi Francesco

Published
2023
Full Text
View/download PDF

4. Validation of the Italian version of the Cluster Headache Impact Questionnaire (CHIQ)

Author

Onofri, Agnese, Iannone, Luigi Francesco, Granato, Antonio, Garascia, Gabriele, Bartole, Luca, Manganotti, Paolo, Vollono, Catello, Romozzi, Marina, Sottani, Costanza, Calabresi, Paolo, Tassorelli, Cristina, Sances, Grazia, Allena, Marta, De Icco, Roberto, De Cesaris, Francesco, Burgalassi, Andrea, Chiarugi, Alberto, Baraldi, Carlo, Guerzoni, Simona, Prudenzano, Maria Pia, Fallacara, Adriana, Albanese, Maria, Rainero, Innocenzo, Coppola, Gianluca, Casalena, Alfonsina, Mampreso, Edoardo, Pistoia, Francesca, Sarchielli, Paola, Morson, Marisa, Sacco, Simona, Geppetti, Pierangelo, and Ornello, Raffaele

Published
2023
Full Text
View/download PDF

5. Primary headache epidemiology in children and adolescents: a systematic review and meta-analysis

Author

Onofri, Agnese, Pensato, Umberto, Rosignoli, Chiara, Wells-Gatnik, William, Stanyer, Emily, Ornello, Raffaele, Chen, Hui Zhou, De Santis, Federico, Torrente, Angelo, Mikulenka, Petr, Monte, Gabriele, Marschollek, Karol, Waliszewska-Prosół, Marta, Wiels, Wietse, Boucherie, Deirdre M., Onan, Dilara, Farham, Fatemeh, Al-Hassany, Linda, and Sacco, Simona

Published
2023
Full Text
View/download PDF

8. Gender-related stress factors and emotional perception in migraine: a structured online questionnaire in migraine patients and controls

Author

Delussi, Marianna, primary, Piraino, Giulia, additional, Guerzoni, Simona, additional, Castro, Flavia Lo, additional, Sances, Grazia, additional, Guaschino, Elena, additional, Vaghi, Gloria, additional, Grazzi, Licia, additional, Sacco, Simona, additional, Onofri, Agnese, additional, Paparella, Giulia, additional, Prudenzano, Maria Pia, additional, Roca, Maria Elena, additional, Fallacara, Adriana, additional, Cevoli, Sabina, additional, Pierangeli, Giulia, additional, Sarchielli, Paola, additional, Bellotti, Alessia, additional, Invitto, Sara, additional, and de Tommaso, Marina, additional

Published
2023
Full Text
View/download PDF

9. Primary headache epidemiology in children and adolescents:a systematic review and meta-analysis

Author

Onofri, Agnese, Pensato, Umberto, Rosignoli, Chiara, Wells-Gatnik, William, Stanyer, Emily, Ornello, Raffaele, Chen, Hui Zhou, De Santis, Federico, Torrente, Angelo, Mikulenka, Petr, Monte, Gabriele, Marschollek, Karol, Waliszewska-Prosół, Marta, Wiels, Wietse, Boucherie, Deirdre M., Onan, Dilara, Farham, Fatemeh, Al-Hassany, Linda, Sacco, Simona, Onofri, Agnese, Pensato, Umberto, Rosignoli, Chiara, Wells-Gatnik, William, Stanyer, Emily, Ornello, Raffaele, Chen, Hui Zhou, De Santis, Federico, Torrente, Angelo, Mikulenka, Petr, Monte, Gabriele, Marschollek, Karol, Waliszewska-Prosół, Marta, Wiels, Wietse, Boucherie, Deirdre M., Onan, Dilara, Farham, Fatemeh, Al-Hassany, Linda, and Sacco, Simona

Abstract

Introduction: Headache is the most prevalent neurological manifestation in adults and one of the leading causes of disability worldwide. In children and adolescents, headaches are arguably responsible for a remarkable impact on physical and psychological issues, yet high-quality evidence is scarce. Material and methods: We searched cross-sectional and cohort studies in Embase, Medline, Web of Science, and Cochrane databases from January 1988 to June 2022 to identify the prevalence of headaches in 8–18 years old individuals. The risk of bias was examined with the Joanna Briggs Institute (JBI) scale. A random-effects model was used to estimate the pooled prevalence of pediatric headache. Subgroup analyses based on headache subtypes were also conducted. Results: Out of 5,486 papers retrieved electronically, we identified 48 studies that fulfilled our inclusion criteria. The pooled prevalence of primary headaches was 11% for migraine overall [95%CI: 9–14%], 8% for migraine without aura (MwoA) [95%CI: 5–12%], 3% for migraine with aura (MwA) [95%CI:2–4%] and 17% for tension-type headache (TTH) [95% CI: 12–23%]. The pooled prevalence of overall primary headache in children and adolescents was 62% [95% CI: 53–70%], with prevalence in females and males of 38% [95% CI: 16–66%] and 27% [95% CI: 11–53%] respectively. After the removal of studies ranked as low-quality according to the JBI scale, prevalence rates were not substantially different. Epidemiological data on less common primary headaches, such as trigeminal autonomic cephalalgias, were lacking. Conclusion: We found an overall remarkably high prevalence of primary headaches in children and adolescents, even if flawed by a high degree of heterogeneity. Further up-to-date studies are warranted to complete the picture of pediatric headache-related burden to enhance specific public interventions.

Published
2023

10. Primary headache epidemiology in children and adolescents: a systematic review and meta-analysis

Author

European Headache Federation School of Advanced Studies (EHF-SAS), Onofri, Agnese, Pensato, Umberto, Rosignoli, Chiara, Wells-Gatnik, William, Stanyer, Emily, Ornello, Raffaele, Chen, Hui Zhou, De Santis, Federico, Torrente, Angelo, Mikulenka, Petr, Monte, Gabriele, Marschollek, Karol, Waliszewska-Prosół, Marta, Wiels, Wietse, Boucherie, Deirdre M, Onan, Dilara, Farham, Fatemeh, Al-Hassany, Linda, Sacco, Simona, Faculty of Medicine and Pharmacy, Brussels Heritage Lab, Faculty of Arts and Philosophy, Clinical sciences, Neurology, and Neuroprotection & Neuromodulation

Subjects
Male, Adult, Migraine without Aura, Adolescent, Migraine with Aura, General Medicine, Headache/epidemiology, Cross-Sectional Studies, Anesthesiology and Pain Medicine, Prevalence, Humans, Female, Neurology (clinical), Child, Tension-Type Headache/epidemiology
Abstract

Introduction Headache is the most prevalent neurological manifestation in adults and one of the leading causes of disability worldwide. In children and adolescents, headaches are arguably responsible for a remarkable impact on physical and psychological issues, yet high-quality evidence is scarce. Material and methods We searched cross-sectional and cohort studies in Embase, Medline, Web of Science, and Cochrane databases from January 1988 to June 2022 to identify the prevalence of headaches in 8–18 years old individuals. The risk of bias was examined with the Joanna Briggs Institute (JBI) scale. A random-effects model was used to estimate the pooled prevalence of pediatric headache. Subgroup analyses based on headache subtypes were also conducted. Results Out of 5,486 papers retrieved electronically, we identified 48 studies that fulfilled our inclusion criteria. The pooled prevalence of primary headaches was 11% for migraine overall [95%CI: 9–14%], 8% for migraine without aura (MwoA) [95%CI: 5–12%], 3% for migraine with aura (MwA) [95%CI:2–4%] and 17% for tension-type headache (TTH) [95% CI: 12–23%]. The pooled prevalence of overall primary headache in children and adolescents was 62% [95% CI: 53–70%], with prevalence in females and males of 38% [95% CI: 16–66%] and 27% [95% CI: 11–53%] respectively. After the removal of studies ranked as low-quality according to the JBI scale, prevalence rates were not substantially different. Epidemiological data on less common primary headaches, such as trigeminal autonomic cephalalgias, were lacking. Conclusion We found an overall remarkably high prevalence of primary headaches in children and adolescents, even if flawed by a high degree of heterogeneity. Further up-to-date studies are warranted to complete the picture of pediatric headache-related burden to enhance specific public interventions.

Published
2023

11. Additional file 1 of Primary headache epidemiology in children and adolescents: a systematic review and meta-analysis

Author

Onofri, Agnese, Pensato, Umberto, Rosignoli, Chiara, Wells-Gatnik, William, Stanyer, Emily, Ornello, Raffaele, Chen, Hui Zhou, De Santis, Federico, Torrente, Angelo, Mikulenka, Petr, Monte, Gabriele, Marschollek, Karol, Waliszewska-Prosół, Marta, Wiels, Wietse, Boucherie, Deirdre M., Onan, Dilara, Farham, Fatemeh, Al-Hassany, Linda, and Sacco, Simona

Abstract

Additional file 1. Searchstrategy

Published
2023
Full Text
View/download PDF

12. Additional file 2 of Primary headache epidemiology in children and adolescents: a systematic review and meta-analysis

Author

Onofri, Agnese, Pensato, Umberto, Rosignoli, Chiara, Wells-Gatnik, William, Stanyer, Emily, Ornello, Raffaele, Chen, Hui Zhou, De Santis, Federico, Torrente, Angelo, Mikulenka, Petr, Monte, Gabriele, Marschollek, Karol, Waliszewska-Prosół, Marta, Wiels, Wietse, Boucherie, Deirdre M., Onan, Dilara, Farham, Fatemeh, Al-Hassany, Linda, and Sacco, Simona

Abstract

Additional file 2. Supplementary table A and B

Published
2023
Full Text
View/download PDF

16. sj-pdf-1-cep-10.1177_0333102420965139 - Supplemental material for I stay at home with headache. A survey to investigate how the lockdown for COVID-19 impacted on headache in Italian children

Author

Papetti, Laura, Loro, Pierfrancesco Alaimo Di, Tarantino, Samuela, Grazzi, Licia, Guidetti, Vincenzo, Parisi, Pasquale, Raieli, Vincenzo, Sciruicchio, Vittorio, Termine, Cristiano, Toldo, Irene, Tozzi, Elisabetta, Verdecchia, Paola, Carotenuto, Marco, Battisti, Matteo, Celi, Angela, D'Agnano, Daniela, Faedda, Noemi, Ferilli, Michela AN, Grillo, Giovanni, Natalucci, Giulia, Onofri, Agnese, Pelizza, Maria Federica, Ursitti, Fabiana, Vasta, Michelangelo, Velardi, Margherita, Balestri, Martina, Moavero, Romina, Vigevano, Federico, and Valeriani, Massimiliano

Subjects
FOS: Psychology, FOS: Clinical medicine, 170199 Psychology not elsewhere classified, 110319 Psychiatry (incl. Psychotherapy), 110306 Endocrinology, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, 110904 Neurology and Neuromuscular Diseases, Neuroscience
Abstract

Supplemental material, sj-pdf-1-cep-10.1177_0333102420965139 for I stay at home with headache. A survey to investigate how the lockdown for COVID-19 impacted on headache in Italian children by Laura Papetti, Pierfrancesco Alaimo Di Loro, Samuela Tarantino, Licia Grazzi, Vincenzo Guidetti, Pasquale Parisi, Vincenzo Raieli, Vittorio Sciruicchio, Cristiano Termine, Irene Toldo, Elisabetta Tozzi, Paola Verdecchia, Marco Carotenuto, Matteo Battisti, Angela Celi, Daniela D'Agnano, Noemi Faedda, Michela AN Ferilli, Giovanni Grillo, Giulia Natalucci, Agnese Onofri, Maria Federica Pelizza, Fabiana Ursitti, Michelangelo Vasta, Margherita Velardi, Martina Balestri, Romina Moavero, Federico Vigevano and, Massimiliano Valeriani; on behalf of the Italian Headache Society (SISC) specific interest group on pediatric headaches in Cephalalgia

Published
2020
Full Text
View/download PDF

17. I stay at home with headache. A survey to investigate how the lockdown for COVID-19 impacted on headache in Italian children

Author

Papetti, Laura, primary, Alaimo Di Loro, Pierfrancesco, additional, Tarantino, Samuela, additional, Grazzi, Licia, additional, Guidetti, Vincenzo, additional, Parisi, Pasquale, additional, Raieli, Vincenzo, additional, Sciruicchio, Vittorio, additional, Termine, Cristiano, additional, Toldo, Irene, additional, Tozzi, Elisabetta, additional, Verdecchia, Paola, additional, Carotenuto, Marco, additional, Battisti, Matteo, additional, Celi, Angela, additional, D'Agnano, Daniela, additional, Faedda, Noemi, additional, Ferilli, Michela AN, additional, Grillo, Giovanni, additional, Natalucci, Giulia, additional, Onofri, Agnese, additional, Pelizza, Maria Federica, additional, Ursitti, Fabiana, additional, Vasta, Michelangelo, additional, Velardi, Margherita, additional, Balestri, Martina, additional, Moavero, Romina, additional, Vigevano, Federico, additional, and Valeriani, Massimiliano, additional

Published
2020
Full Text
View/download PDF

21. Impact of duration of chronic migraine on long‐term effectiveness of monoclonal antibodies targeting the calcitonin gene‐related peptide pathway—A real‐world study.

Author

Ornello, Raffaele, Baldini, Francesca, Onofri, Agnese, Rosignoli, Chiara, De Santis, Federico, Burgalassi, Andrea, Chiarugi, Alberto, Geppetti, Pierangelo, Sacco, Simona, and Iannone, Luigi Francesco

Subjects
*CALCITONIN gene-related peptide, *MIGRAINE, *MONOCLONAL antibodies, *OLDER patients, *DISEASE duration
Abstract

Objective Background Methods Results Conclusions We assessed whether the effectiveness of monoclonal antibodies (mAbs) targeting the calcitonin gene‐related peptide (CGRP) pathway changes according to the duration of chronic migraine (CM) over 12 months.In most patients, CM is a progressive disease starting with episodic migraine. Longer CM duration might be associated with more difficult treatment, probably because the mechanisms underlying chronicization are strengthened. Therefore, early treatment of CM could lead to better outcomes compared with later treatment.This cohort study included individuals with CM treated with anti‐CGRP mAbs in two tertiary headache centers from April 2019 to May 2023. The primary outcome included a change in monthly migraine days (MMDs) from baseline to the third trimester of treatment, 10–12 months. Secondary outcomes established whether response to anti‐CGRP mAbs has a more rapid onset in individuals with shorter CM duration compared with longer duration; they included change in MMDs, monthly headache days (MHDs), and days and number of intakes of acute medication during each trimester compared to baseline. Additional outcomes included persisting MMDs, MHDs, and days and number of intakes of acute medication during each trimester of treatment. Patients were compared across tertiles of the overall CM duration.The study included 335 individuals with CM, with a median (interquartile range [IQR]) age of 48 (39–57) years; 270 (80.6%) were women. Patients in the highest tertile of CM duration (aged 18–60 years) were older than patients in the lower duration tertiles (0–7 years and 8–18 years, respectively), with a median (IQR) age of 56 (48–64) years compared with 42 (31–50) years, and 48 (39–56)years, respectively (p = 0.025); however, this difference was likely due to a correlation between age and disease duration. The change in MMDs from baseline to the last trimester of treatment (10–12 months) was comparable across tertiles of CM duration (median [IQR] −12 [−18 to −5] days, −12 [−17 to −6] days, and −12 [−18 to −4] days; p = 0.946). No difference emerged in secondary outcomes, suggesting a similar time to onset of anti‐CGRP mAbs effect across all tertiles of CM duration.Our data showed that anti‐CGRP mAbs are effective and have a rapid onset of action in CM regardless of disease duration. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results